Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT01822756 |
| Title | An Open-Label Study of Ruxolitinib Given With Chemotherapy in Patients With Advanced Solid Tumors |
| Recruitment | Terminated |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Incyte Corporation |
| Indications | |
| Therapies | |
| Age Groups: | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Birmingham | Alabama | United States | Details | |||
| Gainesville | Florida | United States | Details | |||
| Sarasota | Florida | United States | Details | |||
| Durham | North Carolina | United States | Details | |||
| Nashville | Tennessee | United States | Details |